CN210683364U

CN210683364U - Intelligent tracing and dosing device

Info

Publication number: CN210683364U
Application number: CN201921587235.XU
Authority: CN
Inventors: 纪道勇; 纪汉娇; 刘颖; 伍双远
Original assignee: Wuhan Century Shenjiang Mechanical And Electrical Engineering Co Ltd
Current assignee: Wuhan Century Shenjiang Mechanical And Electrical Engineering Co Ltd
Priority date: 2019-09-24
Filing date: 2019-09-24
Publication date: 2020-06-05
Anticipated expiration: 2029-09-24

Abstract

The utility model discloses an intelligence trace charge device, including medicine system and monitored control system, the medicine system includes main circulating line, the bypass pipeline, medicament storage tank and the fluorescence probe that follow main circulating line and draw forth, the fluorescence probe setting on the bypass pipeline, the medicament storage tank link to each other with the measuring pump, the medicine export of measuring pump communicates with each other with the bypass pipeline, the medicament storage tank facial make-up is equipped with the motor, the output shaft of motor extends to the medicament storage tank and is equipped with the (mixing) shaft, and the embedded resistance wire of having installed of bypass pipeline. The utility model discloses an external bypass pipeline on main circulating line, the resistance wire is installed in the embedding of bypass pipeline, through the resistance wire circular telegram, heats medicament and the rivers temperature in the bypass pipeline, improves the temperature of medicament reaction to make the medicament wholly be in best reaction temperature, improve the scale reaction rate in medicament and the circulating water system, thereby make under the prerequisite of minimum medicament volume, guarantee circulating water system's scale removal effect.

Description

Intelligent tracing and dosing device

Technical Field

The utility model relates to a charge device of circulating water, more specifically relates to an intelligence spike charge device.

Background

At the present stage, in order to solve the problem that the contents of a circulating water system are easy to scale and corrode, a mode of adding chemicals into the system is generally adopted, the concentration of the chemicals in the circulating water is detected after the chemicals are added, and then the opening degree of a chemical adding pump is adjusted according to the concentration of the chemicals. Because of more parameters, if manual operation is adopted and the control is difficult, the dosage is often excessive, and the waste of circulating water and medicament is caused; or the dosage is insufficient, which causes the deterioration of water quality, leads to the corrosion or scaling of water using equipment and seriously influences the service life of pipeline equipment. This way of detecting the concentration of the agent lags the current concentration in the circulating water system significantly.

In order to solve the technical problem, chinese patent CN206384869U provides an intelligent tracing and dosing device, which comprises a dosing system and a control system, wherein the dosing system comprises a main circulation pipeline, a bypass pipeline led out from the main circulation pipeline, a reagent storage tank, a metering pump, a pH meter, a conductivity meter, and a fluorescent tracer, the pH meter, the conductivity meter, and the fluorescent tracer are arranged on the bypass pipeline, the reagent storage tank is connected with the metering pump, and a dosing outlet of the metering pump is communicated with the bypass pipeline. The pH value and the conductivity in the circulating water system are detected through the pH meter and the conductivity meter, the PLC receives and analyzes real-time detection data of the pH meter and the conductivity meter, then the metering pump is controlled to be started, the dosing amount and the dosing time are regulated and controlled, meanwhile, the content of a fluorescent agent in circulating water detected through the fluorescent tracer is analyzed to be the concentration of a water treatment agent, and then whether circulating water needs to be replaced and how much the circulating water needs to be replaced is judged through the measured concentration.

Although the problem of inaccurate medicament addition of a circulating water system caused by medicament concentration lag detection is solved to a certain extent by the structure, the medicament is still added at a normal temperature state in the use process, the medicament plays a role under the influence of water temperature, the same effect is achieved, the medicament addition amount is more than that required actually, the content of the medicament in the circulating water is increased, the cost is increased, and the water quality of the circulating water is influenced.

SUMMERY OF THE UTILITY MODEL

The utility model provides an agent use amount is low, the descaling is effectual and to the little intelligent tracer charge device of circulating water quality of water influence effect to solve the technical problem that current intelligent tracer charge device agent addition is too much, the agent does not completely influence circulating water quality of water in the circulating water reaction.

According to an aspect of the utility model, an intelligence trace charge device is provided, including charge system and monitored control system, charge system includes main circulating line, the bypass pipeline that draws forth from main circulating line, medicament storage tank and fluorescence probe, fluorescence probe set up on the bypass pipeline, the medicament storage tank link to each other with the measuring pump, the medicine outlet and the bypass pipeline of measuring pump communicate with each other, the medicament storage tank facial make-up is equipped with the motor, the output shaft of motor extends to the medicament storage tank and is equipped with the (mixing) shaft, be equipped with electronic flow control valve on the bypass pipeline, and the embedded resistance wire that has installed of bypass pipeline; the monitoring system is electrically connected with the electric flow control valve and the motor respectively.

On the basis of the scheme, the monitoring system comprises a PLC (programmable logic controller) and a network communication module, the PLC is connected with the fluorescent probe and used for receiving real-time detection data of the fluorescent probe, the electric flow control valve and the motor are respectively electrically connected with the PLC, and the network communication module receives signals transmitted by the PLC and is in wireless connection with a monitoring center server.

On the basis of the scheme, preferably, the PLC is provided with an audible and visual alarm for sending out an alarm signal when equipment fails.

On the basis of the scheme, preferably, a temperature sensor is further arranged in the bypass flow pipeline and is electrically connected with the PLC.

Preferably, on the basis of the scheme, the resistance wire is externally connected with a power supply, and the power supply is electrically connected with the PLC.

The utility model discloses an intelligence spike charge device, through an external bypass flow pipeline on main circulating line, the resistance wire is installed in the embedding in bypass flow pipeline, through the resistance wire circular telegram, medicament and the rivers temperature in the heating bypass flow pipeline improve the temperature of medicament reaction to make the medicament wholly be in best reaction temperature, improve the scale reaction rate in medicament and circulating water system, thereby make under the prerequisite of minimum medicament volume, guarantee circulating water system's scale removal effect.

Meanwhile, the utility model discloses still adorn at the medicament jar and establish the motor, it is rotatory to drive the (mixing) shaft through the motor to make the medicament jar on the measuring pump output medicament even, guarantee the effective weight of medicament.

Drawings

FIG. 1 is a block diagram of the intelligent tracing and dosing device of the present invention;

fig. 2 is a structural sectional view of the bypass flow pipe of the present invention.

Detailed Description

The following detailed description of the embodiments of the present invention is provided with reference to the accompanying drawings and examples. The following examples are intended to illustrate the invention, but are not intended to limit the scope of the invention.

In the description of the present invention, it is to be understood that the terms "center", "longitudinal", "lateral", "length", "width", "thickness", "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", "clockwise", "counterclockwise", "axial", "radial", "circumferential", and the like, indicate the orientation or positional relationship based on the orientation or positional relationship shown in the drawings, and are only for convenience of description and simplicity of description, and do not indicate or imply that the device or element referred to must have a particular orientation, be constructed and operated in a particular orientation, and therefore, should not be construed as limiting the present invention.

In the present invention, unless otherwise expressly stated or limited, the terms "mounted," "connected," and "fixed" are to be construed broadly and may, for example, be fixedly connected, detachably connected, or integrally formed; either directly or indirectly through intervening media, either internally or in any other relationship. The specific meaning of the above terms in the present invention can be understood according to specific situations by those skilled in the art.

It should be noted that, in the description of the present invention, the terms "first" and "second" are only used for convenience in describing different components, and are not to be construed as indicating or implying a sequential relationship, relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include at least one such feature.

Please refer to fig. 1, the utility model discloses an intelligence trace charge device, including medicine system and monitored control system 60, wherein, the utility model discloses a medicine system includes main circulating line 10, the side stream pipeline 20, medicament storage tank 30 and the fluorescence probe 54 of drawing forth from main circulating line 10, and the feed inlet and the discharge gate of side stream pipeline 20 are linked together with main circulating line 10 respectively, and fluorescence probe 54 sets up on side stream pipeline 20, and medicament storage tank 30 is linked together with side stream pipeline 20 through measuring pump 40.

When the device is used, the fluorescent agent and the water treatment agent are mixed according to a certain proportion and are arranged in the agent storage tank 30, the agent in the agent storage tank 30 is led into the bypass flow pipeline 20 through the metering pump 40, the content or the concentration of the agent is obtained through the fluorescent probe 54, and whether the requirement of circulating water is met or not is judged through the obtained concentration.

It is worth explaining, in order to prevent that medicament and fluorescent agent separation or mixing ratio are inhomogeneous, the influence detects the accuracy, the utility model discloses still be equipped with motor 50 at medicament storage tank 30 facial make-up, motor 50's output shaft extends to medicament storage tank 30 and is equipped with (mixing) shaft 51, and rotation through motor 50 can drive (mixing) shaft 51 rotatory to with

The utility model discloses still be equipped with electronic flow control valve 52 on bypass flow pipeline 20, and the embedded resistance wire 53 that is equipped with of bypass flow pipeline 20, can pass through electronic flow control valve 52 during the use with the speed that the medicament in control bypass flow pipeline 20 enters into main circulating line 10 to cooperate resistance wire 53, can realize the heating to the medicament in bypass flow pipeline 20, thereby make the medicament be in the optimum use temperature, in order to guarantee its utilization ratio; the utility model discloses a monitored control system 60 and electric flow control valve 52 and motor 50 electric property respectively link to each other, can control electric flow control valve 52's switch and motor 50's function speed through monitored control system 60 to the realization is to the input control of medicament.

The utility model discloses a monitored control system 60 includes PLC controller and network communication module, and the PLC controller links to each other with fluorescence probe 54 and is used for receiving fluorescence probe 54's real-time detection data, electric flow control valve 52 and motor 50 respectively with PLC controller electrical property links to each other, and network communication module receives signal and the wireless connection monitoring center server of PLC controller transmission.

Further, the utility model discloses still set up audible-visual annunciator on the PLC controller for send alarm signal when equipment breaks down.

The utility model discloses still installed the temperature-sensing ware in other flow pipeline 20, the temperature-sensing ware links to each other with PLC controller electrical property, and resistance wire 53 external power supply, power link to each other with PLC controller electrical property.

During the use, can acquire the temperature in the bypass flow pipeline 20 through the temperature-sensing ware to utilize the PLC controller with opening and closing of control power, make the temperature of water in the bypass flow pipeline 20 be in the optimum scope, activate the medicament, thereby make it get into main circulating line 10 after, can exert best effect, avoid medicament incomplete activation to lead to its and the incrustation scale reaction in the circulating water system insufficient, influence its utilization ratio.

The utility model discloses a PLC controller adopts is that the siemens model is 6ES7513-1AL01-0AB 0's controller, and what the temperature-sensing ware adopted is that the TSYS01 digital temperature sensor cooperation NTC liquid temperature probe of beijing saisiwei measurement and control technique limited company, and the utility model discloses a fluorescence probe 54 that the adoption is that the model of the good appearance precision instruments limited company of Guangzhou is JY-DY 2900's fluorescence probe 54, and the utility model discloses a bypass flow pipeline 20 adopts is the PVC pipeline of anti high temperature, and resistance wire 53 imbeds in the PVC pipeline, and the voltage of power is 48V, 12A's power.

The utility model discloses an intelligence spike charge device, through an external bypass flow pipeline 20 on main circulating line 10, install resistance wire 53 in the embedding of bypass flow pipeline 20, through resistance wire 53 circular telegram, medicament and rivers temperature in the heating bypass flow pipeline 20 improve the temperature of medicament reaction, thereby make the medicament whole be in best reaction temperature, improve medicament and circulating water system scale deposit reaction rate, thereby make under the prerequisite of minimum medicament volume, guarantee circulating water system's scale removal effect.

Meanwhile, the utility model discloses still adorn motor 50 on the medicament jar, it is rotatory to drive (mixing) shaft 51 through motor 50 to make the medicament jar on the even of measuring pump 40 output medicament, guarantee the effective weight of medicament.

Finally, the method of the present application is only a preferred embodiment and is not intended to limit the scope of the present invention. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. The utility model provides an intelligence spike medicine device, includes medicine system and monitored control system, its characterized in that: the dosing system comprises a main circulating pipeline, a side flow pipeline led out of the main circulating pipeline, a reagent storage tank and a fluorescent probe, wherein the fluorescent probe is arranged on the side flow pipeline, the reagent storage tank is connected with a metering pump, a dosing outlet of the metering pump is communicated with the side flow pipeline, a motor is arranged on the reagent storage tank, an output shaft of the motor extends to the reagent storage tank and is provided with a stirring shaft, the side flow pipeline is provided with an electric flow control valve, and a resistance wire is embedded in the side flow pipeline; the monitoring system is electrically connected with the electric flow control valve and the motor respectively.

2. The intelligent tracer medication device of claim 1, wherein: the monitoring system comprises a PLC and a network communication module, the PLC is connected with the fluorescent probe and used for receiving real-time detection data of the fluorescent probe, the electric flow control valve and the motor are respectively electrically connected with the PLC, and the network communication module receives signals transmitted by the PLC and is in wireless connection with a monitoring center server.

3. The intelligent tracer medication device of claim 2, wherein: and the PLC is provided with an audible and visual alarm for sending out an alarm signal when the equipment fails.

4. The intelligent tracer medication device of claim 2, wherein: still install temperature-sensing ware in the bypass flow pipeline, temperature-sensing ware with PLC controller electrical property links to each other.

5. The intelligent tracer medication device of claim 2, wherein: the resistance wire is externally connected with a power supply, and the power supply is electrically connected with the PLC.